Title and Organization:
Michael is a serial entrepreneur with 25 years of experience in the life science and healthcare industries. In 2013, he led a management buyout of Lab21 Ltd's US-based operations to form Selah Genomics Inc. Prior to co-founding Selah Genomics, Michael served as President of Lab21 Inc which was formed following Lab21 Ltd's acquisition of his prior company, Selah Technologies LLC. He founded Selah Technologies LLC to commercialize nanotechnologies licensed from Clemson University. Selah focused these nanotechnologies to enable doctors to see cancer during surgery. Prior to founding Selah Technologies, Michael's career included roles of increasing responsibility in the pharmaceutical sector. Michael serves as Immediate Past Chair of SCBIO, South Carolina's Life Sciences Industry Association. Michael earned his bachelor's degree in Chemical Engineering from North Carolina State University. Selah is located in Greenville, South Carolina. Michael is a Fellow of the sixth class of the Liberty Fellowship and a member of the Aspen Global Leadership Network.